Introduction
Common variable immunodeficiency (CVID), the most frequently occurring form of symptomatic immunodeficiency, is a heterogeneous disease that is most likely due to many different genetic defects [1] [2] [3] [4] . With the advent of early gamma globulin replacement therapy, CVID patients are relatively free from life-threatening infections and have a more prolonged survival [1, 3, 5] . The latter, however, has revealed that CVID can be associated with other problems not due to infectious agents. One of these, CVID enteropathy, is characterized by villous atrophy, malabsorption and diarrhea and occurs in up to 15% of CVID patients in symptomatic form and perhaps in a larger percentage in enteropathy since this manifestation of the disease has not been coupled to a particular asymptomatic form [6] , [7] . No genetic differences accounting for the hypogammaglobulinemia in the subset of patients that develop enteropathy and those that do not have been identified in prior studies or in the present study (see below); thus, a genetic basis for the occurrence of enteropathy is not yet known.
The villous atrophy accompanying CVID enteropathy is histologically similar to that in celiac disease and, as such, is characterized by a lamina propria mononuclear cell infiltration and increased numbers of intra-epithelial lymphocytes; however, the prominent plasma cell infiltration seen in celiac disease is not present [7] . Studies conducted by Malamut et al. [7] , showed that intraepithelial lymphocytes (IELs) in celiac disease differed from those in CVID enteropathy with regard to some natural killer cell markers and the TCR/ phenotype characteristic of that in celiac disease was generally not present in CVID. These differences between CVID and celiac disease were corroborated by recent work showing that the two diseases are also quite distinct in gene profiling studies [8] . Finally, studies of the immunologic features of CVID enteropathy conducted by Mannon et al. [9] revealed that lamina propria T cells extracted from patients with this disease produce increased amounts of IL-12 and IFN- but little if any IL-17. These findings correlate with recent studies showing that increased numbers of innate (CD3 -) ILC3 cells producing IFN- are present in mucosal tissues of patients with CVID but not patients with IBD; thus, these cells may also contribute to the Th1 cytokine bias associated with enteropathy [10] .
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In previous work we have shown using systems biology methodology that total immunoglobulin and IgA deficiency in mice are associated with a remarkable upregulation of gut epithelial interferon-inducible genes accompanied by a down-regulation of GATA4-related metabolic genes [11] . Since these changes were not seen in germfree mice it was clear that they were dependent on one or more organisms in the gut microbiota. These studies therefore suggested that CVID enteropathy may be characterized by the presence of an immune defect that leads to colonization with an organism that is responsible for these multiple gene expression changes. To address this possibility we conducted immunologic studies of CVID patients with and without enteropathy as well as control individuals and found that patients with enteropathy but not those without enteropathy exhibited the interferon gene/metabolic gene imbalance mentioned above. In addition, patients with CVID enteropathy could be distinguished from those without enteropathy by the presence of vanishingly low mucosal IgA levels, irrespective of accompanying serum IgA levels. We then used these immunologic data and accompanying microbiome data to conduct a systems biology and transkingdom network analysis [12] for the identification of a possible candidate bacterium capable of causing villous atrophy and malabsorption in the absence of mucosal IgA secretion.
Results
General clinical immunological and genetic characteristics of the patients under study
The patient/control groups studied here consisted of biopsies of 7 patients with E-CVID, As mentioned in the Introduction, no differences in the presence of genes previously associated with CVID with and without enteropathy has yet been reported. To examine this possibility in the present group of patients the latter were screened at the NIH with targeted Ion Torrent AmpliSeq methodology (see Methods section) which included exome sequencing of genes known to be associated with CVID. These included LRBA, PIK3, CTLA-4, NFKB1, NFKB2, PIK3R1, IKZF1 (IKAROS), ICOS, TNFSF12 (TWEAK), CD19, TNFRSF7 (CD27), IL-21R, TNFRSF13B (TACI), TNFRSF13C (BAFF-R), and TNFSF13 (APRIL). Neither CVID patients with enteropathy (E-CVID patients) nor CVID patients without enteropathy (noE-CVID patients) exhibited deleterious mutations in these specific genes.
Gene expression signature of CVID enteropathy and its accompanying inflammatory and lipid metabolism defects
We started by defining the global gene expression profiles of duodenal biopsy tissues obtained from CVID patients with and without enteropathy as well as in control
individuals using RNA sequencing (see Methods). This analysis revealed 2573 genes that were differentially expressed among the three groups (Figure 1a and Supplementary Table S1 ). Analyzing these gene expression profiles using pairwise comparisons between genes, we then defined gene signatures characteristic of CVID with enteropathy (E-CVID; 1802 genes), CVID without enteropathy (noE-CVID; 210 genes) and a general CVID signature common to both patient groups (all-CVID, 561 Figure S1 ). Next, focusing on the gene expression signature in the various groups (Figure 1b ), we identified the down-regulated and up-regulated genes corresponding to various Gene Ontology categories as defined in Figure 1c . We found that in the E-CVID group but not in the noE-CVID group, down- and Supplementary Table S2 ). Thus, these data expanded our previously reported results about differential regulation of immunity and lipid metabolism in humans with immunodeficiency in that they established for the first time that this phenomenon is a specific feature of CVID enteropathy and is not present in other CVID patients or controls. In addition, the difference in the gene signature in the E-CVID and noE-CVID patients was not influenced by the presence of norovirus infection as no statistically significant differences in gene expression were found in norovirus-positive patient samples relative to the expression in other E-CVID patients.
We next used a gene expression approach to estimate which cells were present in the small intestinal infiltrate in patients with E-CVID as compared to patients with noE-CVID or controls. This consisted of a gene set enrichment analysis (GSEA) in which we determined the array of hematopoietic cell signatures as defined previously in the D-MAP study ( Supplementary Table S3 [13, 14] ) that were enriched in the intestinal gene pool of E-CVID patients compared to the pools of noE-CVID patients or controls. We Furthermore, we observed a trend toward a   reduced presence for memory B cells, plasma cells, naïve CD8+ and CD4+ cells in   biopsies from E-CVID patients compared to biopsies from noE-CVID patients or controls. Finally, the results with respect to CD8+ cells were not influenced by the presence of norovirus infection.
To validate one of the most important inferences about the infiltrating cells derived from the above gene expression analysis, we evaluated levels of CD8+ T cell staining in biopsies of tissues obtained from representative patients. The results confirmed the gene expression analysis in showing increased infiltration of CD8+ T cells in biopsies of E-CVID patients compared to biopsies of noE-CVID patients ( Figure 1f ). Interestingly, this result is compatible with peripheral (circulating) patient cell lymphophenotyping in that E-CVID patients exhibited an increase in the absolute numbers of CD8+ T cells compared to noE-CVID patients. However, this association is tentative because the increase in peripheral cells was not statistically significant. Taken together, these results demonstrate that CVID enteropathy is characterized by a complex Th1/cytotoxic T cellrelated infiltration.
Finally, we used GSEA to demonstrate that among the top "leading edge" genes expressed in CD8+ T cells were those encoding IFNG and HLA class II molecules and for genes expressed in M1 macrophages there were those encoding several chemokines such as CXCL9, CXCL10, CCL19, CCL20, CCL5 as well as transcription factor IRF1 ( Figure 1e ). Since expression of these genes is known to be associated with features of an inflammatory process, their expression by CD8+ T cells and macrophages in E-CVID tissue suggested that these cells are participating or mediating intestinal inflammation (Figure 1f ; Supplementary Table S4 ).
Intestinal IgA levels discriminate CVID patients with and without enteropathy
The trend noted above indicating that E-CVID patients' gene expression exhibited decreased enrichment for memory B cells and plasma cell signatures compared with
expression in noE-CVID patients suggested to us that these cells might be more depleted in the mucosa of the E-CVID group than in the noE-CVID group despite the fact that serum immunoglobulins and IgA levels are similarly low in the two groups ( Figure 2a ). To examine this possibility, we extracted the immunoglobulin transcript levels from the total duodenal RNAseq data and found that mRNA levels of both IgA subclasses (encoded by the IGHA1 and IGHA2 genes) in the mucosa from E-CVID patients were strikingly decreased compared to levels in the mucosa from noE-CVID patients and the levels in the latter group were much closer to those in control individuals ( Figure 2b) . Similarly, levels of gene expression of each of the four subclasses of IgG were also decreased in the E-CVID mucosa compared to noE-CVID mucosa and again levels in noE-CVID were similar to those in controls ( Figure 2b ).
Finally, transcript levels of IgM were also low but in this case the error bars were quite large and the result was therefore ambiguous. It should be noted that overall copy numbers of transcripts coding for IGHA1 was 10 times higher than for IgAH2 and 100 times higher than for IgG genes across all three groups indicating that IgA overall (and IgA1 in particular) is the dominant gut immunoglobulin not only in the control small intestine but also in noE-CVID patient small intestine.
To corroborate these mRNA data at the protein level we performed 
The Bacterial Microbiome in the CVID Duodenum
We next turned our attention to studies characterizing the bacterial microbiome associated with duodenal tissue in CVID. Recognizing that duodenal tissues contain an overwhelming number of human cells compared to microbial cells, we first used a targeted gene approach in which bacterial genes were identified by sequencing 16S ribosomal RNA genes present in bacterial but not in mammalian genomes. Despite previous reports of bacterial overgrowth in fecal material of CVID patients [15] , we did not observe significant differences in bacterial abundance in duodenal biopsies from the E-CVID, noE-CVID and control groups (Supplementary Figure S3 ). Tissues from each of these groups contained bacterial taxa dominated by members of the Proteobacteria, Firmicutes, and Actinobacteria phyla and expressing abundant bacteria in the Gammaproteobacteria and Bacilli classes (Figure 3a ; Supplementary Table S5 ).
Importantly, there were not significant differences between the groups in respect to overall composition as illustrated by PCoA ( Figure 3b ) or global diversity evaluated by the Shannon index ( Figure 3c ). Thus, while comparison of abundance of Operational Taxonomic Units (OTUs) between the groups indicated differential representation of some OTUs at the nominal p value of <0.05, none of differences achieved significance after multiple comparison correction (i.e. low FDR).
In view of the above results, we sought to narrow the universe of bacteria with the potential of causing enteropathy in CVID. First, we took into consideration our results
showing that low mucosal IgA levels discriminated between patients with and without enteropathy ( Figure 2 ). Second, we reasoned that since IgA is known to be protective against pathogens and can regulate commensal microbiota [16] [17] [18] , bacterial species potentially contributing to disease in E-CVID patients would have increased abundance in E-CVID tissue compared to control tissue and would be negatively correlated with IgA levels. To select such bacterial candidates, we combined the results of correlations
between bacterial abundances and IgA gene expression with the results of enrichment of bacteria in E-CVID using a recently developed statistical approach [19, 20] . Thus, out of 582 OTUs detected in duodenal biopsies, we found 45 OTUs (FDR<20%) that were enriched with bacteria potentially involved in enteropathy (red dots in right lower corners in both panels of Figure 3d , Supplementary Table S6 ).
Transkingdom Network Analysis Identifies Candidate Microbes Capable of
Driving CVID Enteropathy
To further identify the microbe or microbes driving CVID enteropathy, we employed transkingdom network analysis, an analytic method that we recently developed [20, 21] and successfully used to identify microbiota causing changes in host phenotypes [12, 22] . Using this method of analysis, we integrated abundances of microbial OTUs with mRNA levels of host genes present in the E-CVID signature and thus formed a network in which microbes with strong connections to altered host genes were revealed. The resulting network ( Figure 4A ) consisted of 1474 human genes and 72 OTUs (45 potential causal and 27 potential protective bacteria, Supplementary Table S7 ) from the microbial candidates previously identified by their association to mucosal IgA levels and abundancies in E-CVID ( Figure 3d ).
Among the OTUs that were both most abundant and highly connected to human upregulated genes (mostly pro-inflammatory) in the majority of patients with E-CVID were OTUs from the Acinetobacter genus, Geobacillus genus and otu_15570 with an ambiguous taxonomy (Figure 4b , Supplementary Table S8 ). The number of edges (i.e. links) in the network connecting Acinetobacter, Geobacillus and otu_15570 with human genes was 29, 28, 28 and fold-change of enrichment in E-CVID over other groups was 28, 3, 44 respectively ( Figure 3d ). Thus, these three OTUs emerged as possible microbes causing E-CVID ( Figure 4b ).
Of these three OTUs, Acinetobacter was the most promising since this genus harbors several known pathobionts (commensal microorganisms that can become pathogens
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under favorable circumstances [23, 24] ) whereas Geobacillus and the otu_15570 bacterium ha ve not been previously associated with human disease. In further studies to identify organisms in these groups at the species level we employed shotgun RNAseq rather than 16S rRNA methodology since the latter was not sufficient to support species resolution. Using this approach, we verified all sequences belonging to the three genera and assigned them to species when possible. We found that whereas shotgun RNAseq analysis did not support species resolution for Geobacillus and otu_15570 (Supplementary Figure S4 , and Supplementary Table S9 ) it did reveal that
Acinetobacter baumannii is the predominant species in the Acinetobacter organism genus identified in duodenal biopsies (Figure 4c ; Supplementary Table S10 ). This bacterium has been found in the human intestine and can be a cause of hospitalacquired nosocomial infection not involving the GI tract, presumably as a result of its resistance to antibiotic treatment [25, 26] , [27] . Furthermore, analysis of the duodenal microbiome of patients/controls in all 3 study groups by 16S rRNA sequencing of duodenal biopsies showed that Acinetobacter was present in the duodenal microbiome in all 7 E-CVID patients, 6/8 noE-CVID patients and 3/7 controls ( Figure 4d ).
Furthermore, direct association with IgA expression levels showed that Acinetobacter had the most significant negative correlation with IGHA1 and IGHA2 (FDR=0.016, with r=-0.76, r=-0.47, respectively) among all detectable taxa. Taking these results together with the outcome of the transkingdom network analysis, it became reasonable to postulate that A. baumannii, acting as a pathobiont, was a significant factor in the development of enteropathy in CVID patients.
We next conducted in vitro experiments to determine if A. baumannii can be a contributing pathobionts in E-CVID. Based on the supposition that macrophages, cells that we found were highly enriched in E-CVID mucosa (Figure 1d and 1e), would be the primary cells responding to A. baumannii and triggering a pro-inflammatory reaction in the CVID intestine, we determined whether A. baumannii can induce macrophages to display inflammatory alterations similar to those observed in CVID enteropathy tissues.
In this experiment, we co-cultured THP-1 macrophages with A. baumannii or with a control bacterium for 6 h and then determined gene alterations occurring in the
macrophages. The control bacterium used in this experiment was Lactobacillus plantarum, a bacterium that was the most abundant in duodenal biopsies from E-CVID patients among those potentially controlled by IgA, but did not fulfill other criteria for candidate pathobionts (see Figure 4b and more details in M&M). We found that A.
baumannii strongly induced expression of interferon type I (IFNB1) and CXCL9, the latter a chemokine involved in M1/Th1 activation ( Figure S6 ). In addition, using global gene expression analysis, we found that A. baumannii induced alterations in the expression of 252 genes (185 Up-and 67 Down-regulated) that were highly concordant with the CVID enteropathy expression profile whereas Lactobacillus plantarum did not ( Figure 4e ). Up-regulated genes included those coding for proteins involved in immune responses such as intracellular microbial nucleic acid sensors (AIM2, IFI16, TLR8), numerous IFN-dependent genes (GBP1, IRF1, STAT1, MX1, IDO1, TAP1, IFI44, OAS2, IFIT1, RSAD2), chemokines (CCL2, CXCL1, CXCL10), and many other innate immune response genes ( Figure 4e ). These in vitro data therefore show that A. baumannii can induce an immune response in macrophages consistent with the induction of the Th1driven inflammation that has been found in E-CVID and thus support the possibility that this bacterium can be a pathobiont contributing to CVID enteropathy.
The Interferon Response in E-CVID Drives Inhibition of Lipid Metabolism in E-
CVID Epithelial Cells
In further studies we examined the relation between the nature of the abnormal immune response dominating enteropathy in E-CVID and lipid malabsorption. As mentioned above, in our previous studies in humans [9] and in mouse model [11] , metabolic alterations in epithelial functions were associated with elevations in both type I and type II interferons. Therefore, we further investigated this phenomenon and observed by type II interferon whereas these interferons together regulated 343 genes ( Figure   5c ).
While most of the interferon-regulated genes (234 genes) were among those upregulated in the gene signature, there were 109 downregulated genes enriched for several metabolic processes ( Supplementary Table S11 ). Furthermore, as in the case of the up-regulated genes, the magnitude of downregulation was much less pronounced with individual IFNs than with both of IFNs (Supplementary Figure S8 ). In an additional analysis focusing on lipid metabolism we found that among genes belonging to the group down-regulated by IFNs in epithelial cell culture, the majority (32 out of 43, 74%) had decreased expression after interferon stimulation similar to that observed in biopsies from CVID patients with enteropathy ( Figure 5d ; Supplementary Table S11 ).
These genes are known to be involved in various aspects of enterocyte lipid metabolism such as fatty acid uptake, transport and biosynthesis (CD36, SLC27, ECHDC2, ACSF2), fatty acid oxidation (ACOX1, ACOX2), cholesterol binding (OSBP2, OSBPL7, HSD17B2), and phospholipid transport (ATP8A2, ATP8B2). To test if these effects of IFNs on lipid metabolic gene expression translates into functional alterations we measured intracellular cholesterol levels. In fact, as predicted by the transcriptomic alterations, we observed a consistent reduction in intracellular cholesterol levels after IFN treatment ( Figure 5e ). Taken together, these results suggested that the upregulation of interferon-related genes in CVID drives changes in epithelial cell metabolism in this disease.
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Discussion
Gastrointestinal (GI) symptoms are diverse and relatively frequent in CVID patients despite IgG-replacement therapy. It has been reported that up to 50% of these patients exhibit various degrees of GI symptomatology and up to 15% of the patients exhibit CVID-associated enteropathy characterized by villous atrophy, malabsorption and severe diarrhea that is potentially life threatening and usually treatable only with further immunosuppression [7, 9] .
A central question that we aimed to address in the present study is why some CVID patients develop enteropathy and others do not. Although it was widely recognized that plasma cell levels and serum IgA levels were decreased in CVID patients, no clear distinction with respect to these features of immunodeficiency was attached to the presence or absence of enteropathy [1, 8] . In the current study we made the unexpected finding that while CVID with and without enteropathy did indeed have diminished serum IgA levels, most if not all of the CVID patients with enteropathy exhibited dramatically decreased IgA expression in the duodenal intestinal tissues compared to their counterparts without enteropathy. This finding strongly suggests that patients with enteropathy exhibit more mucosal immunodeficiency than those without enteropathy and are therefore more at risk for a form of gut infection that could cause enteropathy as extensively discussed below. Prior studies partially support this conclusion in that they showed that CVID patients with relatively low IgA levels were more prone to develop various bacterial and viral infections than other CVID patients [28] , [29] . However, these studies did not show that low mucosal IgA levels was associated with enteropathy; this discrepancy may be related to the sensitivity of the staining procedures used in the prior studies as well as the fact that they did not evaluate patients by assessing mucosal Ig mRNA levels (which in this study corroborated the tissue staining findings). One possible caveat to the above conclusion is that enteropathy only rarely occurs in patients with selective IgA deficiency. However, this can be explained by the fact that patients with this immunodeficiency almost invariable have B cells that produce IgA, albeit at a level lower than that in control individuals. In addition, it has been reported that these patients produce IgG and IgM in the mucosal tissues that partially compensate for the lack of IgA [30] , [31] . A second possible caveat is that enteropathy has not been reported in X-linked immunodeficiency patients who have as profound a deficiency in mucosal IgA levels as CVID patients with enteropathy. A possible explanation for this discrepancy is that CVID patients have an accompanying immunologic abnormality that pre-disposes them to the intense Th1-mediated immune response in the upper intestine that is the actual cause of the villous atrophy and resulting malabsorption. Evidence supporting this view comes from previous studies showing that cells from all CVID cells exhibit an IFN- signature as well as the present study which shows that duodenal tissue from CVID patients with enteropathy exhibit overexpression of IFN genes (see further discussion below). This T cell abnormality could be a primary defect accompanying the disease or, as suggested recently, an abnormality secondary to lack of B cell regulation of Th1 T cell development [32] . In any case, one is led to the conclusion that, while a B cell abnormality manifesting as mucosal IgA deficiency sets the stage for enteropathy-causing infection in CVID and serves as a risk factor for the latter sustained inflammation due to a robust T cell response is also necessary for the development of the main manifestation of enteropathy, villous atrophy and malabsorption.
The above explanation of the immunologic conditions allowing the development of enteropathy introduces the question as to which organism could be causing CVID enteropathy. Early on, infection with Giardia lamblia was noted to occur with increased frequency in CVID and was suggested to be a cause of CVID enteropathy; however, it
became apparent that while eradication of this organism in CVID patients does resolve symptoms of the infection it does not reverse co-existing enteropathy; in addition, in the past decade most patients with enteropathy are free of Giardia infection [9] . In a more recent study of infection in CVID patients it was found that sporadic infection with a variety of bacterial and viral pathogens does occur in CVID, but no evidence that these were causative of enteropathy and in most cases the infection did not cause symptomatic disease [33] . A possible exception to this trend is the possibility that CVID is caused by norovirus infection since this organism has been found in stool and biopsies of some (but not all) patients with this condition [29, 33, 34] . Our molecular analysis of organisms associated with the duodenal specimens showed that CVID patients with and without enteropathy exhibited a relatively low norovirus positivity in biopsies (Supplementary Figure S9 ). This suggests that norovirus alone cannot explain the presence of enteropathy, at least in our patient cohort. It remains possible, however, that this agent is playing a role as an adjuvant to the causative organism as it can induce intestinal inflammation in humans and mice (reviewed in [35] ). Finally, it should be noted that duodenal biopsy specimens were also evaluated by PCR and whole genome RNA sequencing for the presence of enterovirus, adenovirus, astrovirus and rotovirus; only enterovirus was detected in one tissue specimen that happened to be positive for norovirus.
In another study [8] , it was found that the fecal microbiome of CVID patients exhibited a baumannii has been found in the intestine of healthy individuals [36, 37] and we detected this bacterium in both control individuals and patients with CVID without enteropathy, this microbe has been associated with wound, lung and blood i nfections in soldiers and patients in intensive care units [38] [39] [40] [41] [42] . Interestingly, in a very recent study it was found that an Acinetobacter genus was associated with inflammatory cellular and gene expression profiles in IBD patients [43] ; this provides further support for the potential role of these bacteria in gut inflammation
The above studies supporting the idea that A. baumannii is acting as a pathobiont in CVID enteropathy notwithstanding, the possibility exists that other bacteria could also have this role. This follows from the fact that the transkingdom network analysis identified other possible pathobionts in CVID, including , Geobacillus, a bacterium that shares some genetic properties with segmented filamentous bacteria (SFB) and that is well known as an inducer of pro -inflammatory cytokines in the mouse small intestine [44] . Thus, while our study, together with previous mouse data [11] , supports the concept that CVID enteropathy is possibly caused by a pathobiont in the upper GI tract and identified A. baumannii as one such pathobiont, it is likely that other pathobionts will
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be identified which also have this role and are the cause of enteropathy in CVID patients in which this organism is not found.
In the present studies we performed extensive global gene expression profiling that confirmed our previous finding that a Th1-like inflammatory process underlies CVID enteropathy [9] . In addition, it led to the further insight that both type I and II interferons are involved (Fig. 5 ). Interestingly, these findings coincide with a previous study showing up-regulation of IFN-driven gene expression in whole blood cell populations is a feature of CVID patients with a variety of inflammatory complications including those with and without gastrointestinal inflammation [45] . Confirming our previous mouse studies we identify in humans that the shift from metabolic to immune/pro -inflammatory in the small intestine is associated with the development of enteropathy. In addition, we now show that the type I and type II interferons above are responsible for this shift and that, for instance, lipid transport gene expression and intracellular cholesterol levels are directly and adversely affected by interferons. It should be noted, however, that while these metabolic alterations may contribute to the malabsorption characterizing CVID enteropathy the latter is mainly due to cytotoxic effects on epithelial cells arising from the inflammation.
Overall, in this work, we present evidence that CVID enteropathy is uniquely characterized by a severe deficit in mucosal IgA secretion, an abnormality that sets the stage for possible colonization and infection by one or more commensal organisms acting as pathobionts in the IgA-deficient mucosal environment. We have identified A.
baumannii as one such possible pathobionts. CVID enteropathy is also uniquely characterized by a gene profile in which IFN gene expression is greatly increased whereas metabolic gene expression is greatly decreased. This abnormality may contribute to the development of enteropathy by facilitating the robust interferonmediated response necessary to induce villous atrophy and malabsorption. Supplementary Table S14 and Supplementary Table   S15 ). All eligible patients had negative stool testing for pathogens (Salmonella, Shigella 
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Material and Methods
Patients
Endoscopic Biopsy
Endoscopic biopsy specimens were fixed in 10% formalin prior to paraffin embedding and routine staining with H&E. 
Immunohistochemistry and image analysis
Paraffin embedded biopsy tissues were and cut into 5 μm sections. Antigen retrieval was performed at 90C for 20 min and sections were blocked with bovine serum albumin following by staining with anti-IgA (Abcam ab124716) or anti-CD8 (Dako M710301-2) both at a dilution of 1:100. Sections were developed with 3,3'diaminobenzidine (DAB), and counterstained with hematoxylin by HistoServ (Germantown, MD). Slides were imaged using a Leica DM E microscope. For IgA quantification, DAB+ area and total tissue area were quantified from 5-7 randomly selected fields representative of total tissue area. For CD8+ area, the epithelial layer was manually selected from 5-7 randomly fields and DAB+ area and total tissue area were quantified from this selected epithelial area. All image selection, color deconvolution and area quantifications were performed using Fiji [46] .
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Shotgun RNA sequencing and 16S rRNA gene sequencing
Total RNA from biopsies was isolated using TotalPrep RNA/DNA kit (Qiagen) after mechanical homogenization with Omni rotor followed by Qiashredder (Qiagen). For analysis of bacterial 16S rRNA gene expression, 1 microgram of total RNA was reverse transcribed using VILO cDNA synthesis kit with random primers (Invitrogen) and this cDNA was used for qPCR with universal bacterial primers and for 16S rRNA library prep and then sequenced on MiSeq instrument according to a previous protocol [22] . For human gene expression and shotgun metagenomics, libraries were prepared using 
RNA-seq gene expression analysis
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Gene Ontology enrichment analysis of Biological Processes (BP_FAT) was performed using DAVID Bioinformatics Resources 6.7 with threshold gene count 2 and enrichment score p-value <0.01 [47] .
For immunoglobulin expression analysis we retrieved quantile normalized gene expression levels for IGHA1, IGHA2, IGHM, IGHG1, IGHG2, IGHG3, IGHG4.
Cell type enrichment analysis
For M1 and M2 microphages, we used the gene signatures from work of Martinez and co-workers [14] . For all other cell types, we inferred gene signatures using data from Dmap [13] . The signature of a given cell type was defined as a group of genes with at least two-fold higher expression (FDR<0.1) than in other cell types (e.g. T lymphocytes vs other hematopoietic cells), and followed by subdivision of this parent signature by comparing a given cell type with closely related cell types (e.g. naïve vs memory T lymphocytes). Enrichment of gene signatures was performed using Gene Set Enrichment Analysis (GSEA) 2-2.2.3 with default parameters [48] .
Microbiome 16S gene analysis
The raw forward-end fastq reads were quality-filtered, demultiplexed and analyzed using 'quantitative insights into microbial ecology' (QIIME). For quality filtering, the default parameters of QIIME were maintained in which reads containing ambiguous base calls and containing fewer than 187 nt (75% of 250 nt) of consecutive high-quality base calls, were discarded. Additionally, reads with three consecutive low-quality bases were truncated. The samples sequenced were demultiplexed using 12 bp barcodes, allowing 1.5 errors in the barcode. UCLUST was used to choose OTUs with a threshold of 97% sequence similarity against Green gene database (version gg_12_10) A representative set of sequences from each OTU were selected for taxonomic identification of each OTU by selecting the cluster seeds. The Greengenes OTUs (version gg_12_10) reference sequences (97% similarity) were used for taxonomic assignment using BLAST with E_value 0.001. Raw read counts of OTUs were normalized against total number of reads that passed quality filtration to generate relative abundance of OTUs. DNA amount of an OTU in a sample was calculated by
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multiplying relative abundance of the OTU by total amount of bacterial DNA in the corresponding sample. Differentially abundant OTUs were identified using univariatetest in BRB array tools' 'class comparison between groups of arrays' modules. Beta diversity was calculated using QIIME script beta_diversity.py using option -m binary_pearson followed by principal_coordinates.py to generate principle coordinates.
Alpha diversity was calculated using QIIME script alpha_diversity.py for calculating shannon index on randomly subsampling 15003 sequences for each sample. Tree of life graph was generated using the online tool iTOL (http://itol.embl.de/).
Network analysis and causal inference
Overall procedure is described in [49] . In brief, human gene-gene network was reconstructed using following steps. First, for each pair of genes/OTUs, three Pearson correlation coefficients and p-values are calculated using abundance levels of each of the three groups of E-CVID, NoE-CVID, Controls. Second, Fisher combined p-value is calculated from three p-values using Fisher's combined probability test. FDR value is calculated from the combined p-value. The sign of correlation coefficients in three groups should be consistent (all positive correlation or all negative correlation across three groups). Also, we selected correlations that had sign of correlation consistent with possibility of causal relations between genes [19] . Third, human gene-gene network was generated by requiring all p-values of correlation coefficient from three groups <0.05 and combined FDR<0.1. Three human gene expression networks corresponding to three groups of samples were generated by selection and inclusion of gene pairs as following: Individual p-value of correlation within each group was smaller than 0.2;
combined FDR smaller than 0.15.
The bi-partite betweenness centrality calculation is similar to conve ntional betweenness centrality except that shortest paths are calculated only between nodes belonging to two different groups of nodes and not between any nodes within the same subnetwork [12, 20] :
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Where s and t are two nodes belonging to two different subnetworks, is the total number of shortest paths from node s to node t and is the number of those paths that pass through v.
We used the scaled betweenness centrality for each network (by requiring individual pvalue <0.05, 0.1 or 0.2) using the formula:
Reconstruction and interrogation of transkingdom network
To select OTUs potentially IgA dependent and differentially represented in E -CVID,
Pearson correlation was calculated between OTU levels and expressions of IgA1 and
IgA2, respectively. P values from two correlation analysis were integrated with t-test result from comparisons between E-CVID and HV using Fisher's test followed by FDR calculations. OTUs that had FDR <=20% were selected for further integration into transkingdom network.
For human gene-microbe transkingdom network reconstruction, we applied the same procedure as for the gene-gene network requiring FDR <0.1. In order to identify potential candidate microbes that promote inflammation we interrogated a transkingdom network that represent a statistical model of interaction between microbiome and host transcriptome [20] . We thought that commonly used network parameters such degree of a given node would not be appropriate to ask our biological question. Therefore, in order to rank OTUs by strength of their potential influence on the host we focused our analysis and counted number of direct links (edges) between a given OTU and upregulated genes in transkingdom network.
Identification of species for OTUs that are potential stimulators of human upregulated immune genes
Transkingdom network analysis revealed several OTU candidates that are abundant in E-CVID and had many connections to human up-regulated immune genes. They are also potential regulators of human immune gene expression. However, 16S-based OTU taxa assignment of these candidates didn't reach species level, thus limited our ability to
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experimentally test their functions. To better characterize the candidate OTUs, we utilized shotgun metatranscriptomic data derived from the same samples to profile abundance of species from the same most detailed taxa level (genus/family/order) of the candidate OTUs. We assign reads from shotgun metatranscriptomic to species based on our previous procedure [12] . Briefly, we aligned reads to reference protein database then used MEGAN5 to transfer the taxa of proteins to the reads that aligned to them. For the OTU denovo96904 (assigned to genus Geobacillus), we found that there are four Geobacillus species with similar abundance detected in the samples (Supplementary Figure S4 ). In this case there was not enough information to determine which species denovo96904 corresponds to. For the OTU denovo15570 (assigned to order Stramenopiles), we didn't detect species from this order using shotgun metatranscriptomic data. We then took the representative 16s rRNA amplicon sequence of this OTU to search against NCBI nt database to figure out which species it came from. The result ( Supplementary Table S9 ) indicated that there were many species sharing the exact same 16s rRNA region, including Cyclotella and uncharacterized bacterium. Thus, we were unable to obtain species information for the two candidates except the Acinetobacter OTU denovo56853 (Acinetobacter baumannii).
Technical parameters utilized for shotgun analysis of RNA-seq data to establish individual microbes corresponding to candidate OTUs
Sequences with at least one ambiguous nucleotide were filtered out by prinseq.
Trimmomatic was used to filter out Illumina adaptor sequences (under parameters: seed mismatches: 1, palindrome clip threshold: 10 and simple clip threshold: 10), to remove leading and trailing low quality bases (below quality 3), to scan the read with a 4 -base wide sliding window, and to cut when the average quality per base drops below 20 and to drop reads that are below 60 bases long. Human sequences were filtered out by aligning reads against human genome (hg19) using Bowtie2 under default parameters.
Around 82% of original reads passed filter steps and subject to downstream analysis.
Taxonomic assignment of reads was carried out using DIAMOND a lignment against the integrated nonredundant protein database (ftp://ftp.ncbi.nlm.nih.gov/blast/db/nr.tar.gz).
DIAMOND alignment hits with e-values larger than 0.001 were filtered out, and for each read, top 20 hits were retained to distinguish taxonomic groups. The taxonomical level
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of each read was determined by the lowest common ancestor (LCA)-based algorithm that was implemented in MEGAN4. In this algorithm, if a read had significant alignment hit in many species, it was assigned to the LCA instead of a species. Megan4 parameters were set to: min support=1, min score=50, min complexity=0.44, top percent=10, win score=0.
Selection of control bacterium
To select bacterial candidate that would serve as a control for A. baumannii as common commensal bacteria in duodenum that does not contribute to E-CVID according to our analysis. We wanted this bacterium being similar A. baumannii to for all features except 
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co-incubation with human cells, one colony from the LB agar plate was inoculated in 10 ml LB broth, incubated at 37°C with shaking at 200 rpm for 8-9 hours and OD600 was checked. This OD600 was used to interpolate the CFU in the broth using the established growth curve.
Lactobacillus plantarum (DSM 12028) was streaked out from -80°C on de Man, Rogosa and Sharpe (MRS) agar (Hardy Diagnostics) plate and incubated overnight in anaerobic conditions using GasPak EZ Gas Generating Container Systems (BD, Catalog# 260001) at 37°C. The correspondence between CFU and OD600 was established using the same method as for A. baumannii except using MRS medium and anaerobic conditions without shaking. To co-incubate the cells, one colony from the agar plate was inoculated in 10 ml MRS broth (Hardy Diagnostics) and incubated anaerobically as above for 8-9 hours. OD600 was checked and used to determine CFU.
Co-incubation of bacteria with THP-1 Cells
Human myelomonocytic leukemia cells line THP- (SRSF11) was selected according to the procedure described in previous publication [50] . For list of primers see Supplementary Table S12 . 
Measurements of total cholesterol concentrations in
Norovirus detection in duodenal biopsies
Norovirus strains were genotyped by partial nucleotide sequencing of the polymerase gene. Briefly, total RNA isolated from duodenal biopsies was reverse transcribed and fragments of the norovirus polymerase gene were amplified using primers designed to detect both sapo-and noroviruses [51] . 
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Data Sharing
All sequencing data were deposited to European Nucleotide Archive under accession number PRJEB18593.
Author Contributions
Conceived baumannii. Representative genes are indicated and levels of expression of the same genes in biopsies with E-CVID or noE-CVID are shown; full list of genes is in Supplementary Table S13 . 
